tiprankstipranks
Synthetic Biologics Inc (SYN)
NYSE MKT:SYN
Holding SYN?
Track your performance easily

Synthetic Biologics (SYN) Financial Statements

0 Followers

Synthetic Biologics Financial Overview

Synthetic Biologics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Synthetic Biologics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -4.99M$ -4.25M$ -5.26M$ -3.27M$ -3.20M
EBITDA$ -4.97M$ -4.23M$ -5.25M$ -3.26M$ -3.17M
Net Income Common Stockholders$ -4.97M$ -4.27M$ -5.26M$ -3.27M$ -3.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.00M$ 6.23M$ 52.27M$ 56.69M$ 67.33M
Total Assets$ 82.33M$ 89.00M$ 70.36M$ 75.12M$ 77.25M
Total Debt$ 232.00K$ 361.00K$ 445.00K$ 1.59M$ 1.60M
Net Debt$ -5.77M$ -5.87M$ -51.82M$ -55.10M$ -65.73M
Total Liabilities$ 20.66M$ 20.97M$ 4.96M$ 4.56M$ 3.52M
Stockholders Equity$ 6.68M$ 8.03M$ 61.67M$ 65.41M$ 68.03M
Cash Flow-
Free Cash Flow$ -4.37M$ -4.90M$ -4.81M$ -2.16M$ -2.60M
Operating Cash Flow$ -4.36M$ -4.90M$ -4.81M$ -2.16M$ -2.60M
Investing Cash Flow$ -14.00K$ -4.28M$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ -1.38M$ 0.00$ 0.00$ 0.00
Currency in USD

Synthetic Biologics Earnings and Revenue History

Synthetic Biologics Debt to Assets

Synthetic Biologics Cash Flow

Synthetic Biologics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis